Paloma Ordóñez-Morán
Present address: Swiss Institute for Experimental Cancer Research, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
These authors contributed equally: Stephan P. Tenbaum, Paloma Ordóñez-Morán, Isabel Puig.
Vall d’Hebrón Institut d’Oncología (VHIO), Stem Cell and Cancer Laboratory, Barcelona, Spain
Stephan P. Tenbaum, Isabel Puig, Irene Chicote, Oriol Arqués & Héctor G. Palmer
Instituto de Investigaciones Biomédicas ‘Alberto Sols’, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain
Paloma Ordóñez-Morán & Alberto Muñoz
Department of Pathology, Hospital Universitari Vall d’Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
Stefania Landolfi & Santiago Ramón y. Cajal
Group of Drug Delivery and Targeting, Centro de Investigaciones en Bioquímica y Biología Molecular (CIBBIM)–Nanomedicine and Networking Biomedical Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital Universitari Vall d’Hebrón, Institut de Recerca Vall d’Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
Yolanda Fernández & Simó Schwartz Jr
Parc de Recerca Biomèdica de Barcelona (PRBB), Centre d´Imatge Molecular (CRC) Corporació Sanitària, Barcelona, Spain
José Raúl Herance, Juan D. Gispert & Santiago Rojas
VHIO, Genomics Cancer Group, Barcelona, Spain
Leire Mendizabal & Ana Vivancos
Centre for Respiratory Research, Rayne Institute, University College London, London, UK
Susana Aguilar
Hematopoietic Stem Cell Laboratory, London Research Institute, Cancer Research UK, London, UK
Susana Aguilar
General Surgery Service, Hospital Universitari Vall d’Hebrón, Barcelona, Spain
Eloy Espín
Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts, USA
José Baselga
Howard Hughes Medical Institute, Chevy Chase, Maryland, USA
José Baselga
Medical Oncology Department, Hospital Universitari Vall d’Hebrón, Barcelona, Spain
Josep Tabernero
